edelfosine has been researched along with Angiogenesis, Pathologic in 2 studies
edelfosine: RN given refers to parent cpd
edelfosine : A racemate comprising equimolar amounts of (R)- and (S)-edelfosine.
1-octadecyl-2-methylglycero-3-phosphocholine : A glycerophosphocholine that is glycero-3-phosphocholine substituted at positions 1 and 2 by octadecyl and methyl groups respectively.
Excerpt | Relevance | Reference |
---|---|---|
"Edelfosine is an alkyl-lysophospholipid that acts as an anticancer agent in vivo." | 1.30 | The anticancer drug edelfosine is a potent inhibitor of neovascularization in vivo. ( Ades, EW; Bouck, N; Liu, J; Vogler, WR; Volpert, O, 1998) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Candal, FJ | 1 |
Bosse, DC | 1 |
Vogler, WR | 2 |
Ades, EW | 2 |
Liu, J | 1 |
Volpert, O | 1 |
Bouck, N | 1 |
2 other studies available for edelfosine and Angiogenesis, Pathologic
Article | Year |
---|---|
Inhibition of induced angiogenesis in a human microvascular endothelial cell line by ET-18-OCH3.
Topics: Antineoplastic Agents; Cell Adhesion Molecules; Depression, Chemical; Dose-Response Relationship, Dr | 1994 |
The anticancer drug edelfosine is a potent inhibitor of neovascularization in vivo.
Topics: Animals; Antineoplastic Agents; Cattle; Cell Movement; Cells, Cultured; Cornea; Endothelium, Vascula | 1998 |